Zheng Quan Shi Bao·2025-12-08 23:13Group 1: Control Changes in Companies - PIANO (002853) is planning a change in control, with its major shareholder Ma Libin potentially being replaced. The stock will be suspended from trading starting December 9, with a maximum suspension period of two trading days. The company specializes in high-end custom cabinets and related home products [1] - TAILONG PHARMACEUTICAL (600222) announced a share transfer agreement where its controlling shareholder, Zhengzhou Tai Rong Industrial Investment Co., will transfer approximately 8.73% of its shares to Jiang Pharmaceutical Group at a price of 11.043 CNY per share, totaling 553 million CNY. This will result in Jiang Pharmaceutical becoming the new controlling shareholder [3][4] - ST YISHITE (300376) faced complications in its control change process. A previous agreement with Guangwu Group was terminated due to disagreements. However, a new agreement was signed with Hubei Jingjiang Industrial Investment Group to acquire 4.34 billion shares for 2.437 billion CNY, making Jingjiang the new controlling shareholder [6][7] Group 2: Financial Implications - The stock price of PIANO surged to 16.24 CNY per share, with a market capitalization of approximately 3 billion CNY following the announcement of the control change [1] - The share transfer for TAILONG PHARMACEUTICAL will result in Jiang Pharmaceutical holding about 125 million shares, representing 19.23% of the total shares post-issuance [4] - The transaction for ST YISHITE will involve a cash payment of 2.437 billion CNY, with the new controlling shareholder agreeing to waive voting rights for a significant portion of shares for five years [6][7]